NICE:TASENICE Ltd. Analysis
Data as of 2026-07-10 - not real-time
$99.62
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
NICE Ltd. trades well below its peers on valuation metrics, with a price‑earnings multiple that is markedly lower than the industry average and a discounted cash‑flow estimate that suggests substantial upside. Technical gauges show a bullish momentum signal from the MACD histogram while the relative strength index remains comfortably below overbought levels, yet the price is edging toward a short‑term resistance zone and volume is on a downtrend, hinting at a cautious near‑term outlook.
Fundamentally the company delivers solid revenue expansion, healthy margins and strong cash conversion, supported by a low‑beta profile that tempers market swings. The absence of dividend payouts underscores a focus on reinvestment in AI‑driven platforms, and the modest debt load combined with robust free cash flow enhances financial resilience. Overall, the stock appears undervalued with a blend of growth attributes, making it attractive for medium to long‑term investors while short‑term positioning should remain neutral.
Fundamentally the company delivers solid revenue expansion, healthy margins and strong cash conversion, supported by a low‑beta profile that tempers market swings. The absence of dividend payouts underscores a focus on reinvestment in AI‑driven platforms, and the modest debt load combined with robust free cash flow enhances financial resilience. Overall, the stock appears undervalued with a blend of growth attributes, making it attractive for medium to long‑term investors while short‑term positioning should remain neutral.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- bearish trend direction despite bullish MACD
- decreasing volume indicating reduced short‑term interest
- price approaching immediate resistance level
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- valuation gap relative to peers and DCF target
- steady revenue growth and expanding AI portfolio
- low beta suggesting limited volatility
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- long‑run demand for AI‑enabled compliance and customer engagement solutions
- strong cash generation and modest leverage
- strategic positioning in high‑growth technology segment
Key Metrics & Analysis
Financial Health
Revenue Growth9.80%
Profit Margin17.57%
P/E Ratio11.8
ROE14.76%
ROA7.75%
Debt/Equity2.34
P/B Ratio40.6
Op. Cash Flow$610.7M
Free Cash Flow$484.5M
Industry P/E34.7
Technical Analysis
TrendBearish
RSI63.3
Support$83.10
Resistance$100.74
MA 20$91.04
MA 50$94.00
MA 200$111.38
MACDBullish
VolumeDecreasing
Fear & Greed Index94.04
Valuation
Fair Value$167.14
Target Price$131.43
Upside/Downside31.93%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.32
Volatility39.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.